News archives

Appointment of Chairman

20 June 2007

Phytopharm plc (LSE: PYM) (”Phytopharm” or the “Company”) today announces the appointment of Alistair Taylor as Non-Executive Chairman. Mr Taylor will join the Board of Phytopharm plc with effect from 18 July, succeeding Dr Paul Whitney who retires from the Company after 10 years. This appointment completes the planned restructuring of the board.

Cogane™ data presented at ‘11th International Congress of Parkinson’s Disease and Movement Disorders’

5 June 2007

GODMANCHESTER, Cambridgeshire, U.K. (5 June 2007) – Phytopharm plc (LSE: PYM) (”Phytopharm” or the “Company”) announces today pre-clinical data showing that Cogane™ reverses the changes in the area of the brain involved in Parkinson’s disease. This data will be presented by Dr Jonathan Brotchie, an internationally recognised expert on Parkinson’s disease at ‘The 11th International Congress of Parkinson’s Disease and Movement Disorders’ 5 June in Istanbul, Turkey and published in The Movement Disorders Society’s journal*.

Commencement of Phase Ib clinical study for Myogane™

17 May 2007

Phytopharm plc (LSE: PYM) (”Phytopharm” or the “Company”) announces today that it has been granted clearance from the Medicines and Healthcare Products Regulatory Agency (MHRA) and received Research Ethics Committee (REC) approval to commence a Phase Ib healthy volunteer clinical study for Myogane™ in the UK. Myogane ™ is a novel orally active neurotrophic factor inducer being developed for amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease), the most prevalent form of motor neurone disease.

Interim Results for the six months ended 28 February 2007.

1 May 2007

Download press release (PDF, 103KB)

Launch of Phytopica® in France

16 April 2007

Phytopharm plc (LSE: PYM) (”Phytopharm” or the “Company”) today announces the launch of Phytopica® in France by its partner, Schering-Plough Animal Health (”Schering-Plough”). This launch continues the European roll-out of Phytopica®, which follows the launch of Phytopica® in Italy last month.

Launch of Phytopica™ in Italy

26 March 2007

Phytopharm plc (LSE: PYM) (”Phytopharm” or the “Company”) today announces the launch of Phytopica™ in Italy by its partner, Schering-Plough Animal Health (”Schering-Plough”).

Placing of New Ordinary Shares raises £1.7 million

1 March 2007

GODMANCHESTER, Cambridgeshire, U.K. (1March 2007) – Phytopharm plc (LSE: PYM) (”Phytopharm” or the “Company”) today announces that it has raised approximately £1.7 million before expenses (£1.5 million after expenses) by way of a conditional placing (the “Placing”) of 4,425,416 new ordinary shares of 1 pence each in the Company (”Ordinary Shares”). The proceeds will be used to strengthen the Company’s balance sheet and continue the development of its products.

Board Changes

9 January 2007

Phytopharm plc (LSE: PYM; NASDAQBB: PHYOF; PHYOY) (”Phytopharm” or the “Company”) today announces a number of planned changes to its senior management team ahead of the next phase in its development.

Preliminary Results for the year ended 31 August 2006

8 November 2006

Download PDF (207KB)

Board Changes

5 September 2006

Phytopharm plc (LSE: PYM; NASDAQBB: PHYOF; PHYOY) (”Phytopharm”) announces that Gordon Stevens (non-executive Chairman) and Trevor Flanagan (non-executive Director) have today retired from the Board and that Paul Whitney (currently Deputy Chairman) has today stepped up to the role of non-executive Chairman.